NCT01355016View on ClinicalTrials.gov

A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of MDT-637 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions
Drug SafetyRespiratory Syncytial Virus Infections
Interventions
DRUG

MDT-637

Inhaled doses of MDT-637 over a 24 hour period

Trial Locations (1)

90630

West Coast Clinical Trials, Cypress

Sponsors
All Listed Sponsors
lead

MicroDose Therapeutx, Inc

INDUSTRY